RENOVARO INC. - COMMON STOCK

Statement of Renovaro Inc

14 фев 2024 10:01:30 Источник Nasdaq GlobeNewswire

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

13 фев 2024 09:46:07 Источник Nasdaq GlobeNewswire

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

13 фев 2024 09:31:09 Источник Nasdaq GlobeNewswire

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

25 янв 2024 12:45:00 Источник Nasdaq GlobeNewswire

Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD

16 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire

Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors

11 окт 2023 09:25:00 Источник Nasdaq GlobeNewswire

Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors

10 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

02 окт 2023 12:05:40 Источник Nasdaq GlobeNewswire

AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine

02 окт 2023 09:25:00 Источник Nasdaq GlobeNewswire

Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine

29 сен 2023 09:15:00 Источник Nasdaq GlobeNewswire

Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

30 авг 2023 09:15:00 Источник Nasdaq GlobeNewswire

Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer

21 авг 2023 09:15:00 Источник Nasdaq GlobeNewswire

AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer

09 авг 2023 09:00:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting

23 июн 2023 17:00:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

08 июн 2023 08:45:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences’ CEO Letter to Shareholders

03 апр 2023 09:00:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

29 мар 2023 09:00:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

13 мар 2023 08:30:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022

23 фев 2023 16:04:00 Источник Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

30 ноя 2022 17:20:12 Источник Nasdaq GlobeNewswire